How to Encourage the Appropriate Evaluation of Glaucoma among General Medicine Doctors
Leon Herndon, Jennifer E. Threatt
Citation Information :
Herndon L, Threatt JE. How to Encourage the Appropriate Evaluation of Glaucoma among General Medicine Doctors. 2013; 41 (2ENG):8-10.
Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Org 1994;72:323- 6.
Quigley HA, Vitale S. Models of glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997;38:83-91.
Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2004;111:1439-48.
Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 2008;14:224-33.
Tripathi RC, Tripathi BJ, Haggerty C. Drug-Induced Glaucomas: Mechanism and Management. Drug Safety 2003;26.11:749.
Mitchell P, Cumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 1999;106:2301-6.
Tripathi R, Parapuram S, Tripathi B, et al. Corticosteroids and glaucoma risk. Drugs & Aging 1999;15:439-450.
Razeghinejad MR, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to medications. American Journal of Medicine 2011;124: 20-25.
Sheldrick JH, Sharp AJH. Glaucoma screening clinic in general practice: prevalence of occult disease, and resource implications. British Journal of General Practice 1994;44:561-565.
Steinmann WC, Licht E, Siegler JE, Nicholas CW. Screening for Glaucoma by General Medicine Residents. Archives of Internal Medicine 1982;142:785-786.
Kumar S, Giubilato A, Morgan W, Jitskaia L, Barry C, Bulsara M, Constable IJ, Yogesan K. Glaucoma screening: analysis of conventional and telemedicine-friendly devices. Clinical and Experimental Ophthalmology 2007;35:237-243.